| 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome: a consensus and data‐driven methodology … CH Shiboski, SC Shiboski, R Seror, LA Criswell, M Labetoulle, ... Arthritis & rheumatology 69 (1), 35-45, 2017 | 2348 | 2017 |
| American College of Rheumatology classification criteria for Sjögren's syndrome: a data‐driven, expert consensus approach in the Sjögren's International Collaborative Clinical … SC Shiboski, CH Shiboski, LA Criswell, AN Baer, S Challacombe, ... Arthritis care & research 64 (4), 475-487, 2012 | 1582 | 2012 |
| Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial IB McInnes, PJ Mease, B Kirkham, A Kavanaugh, CT Ritchlin, P Rahman, ... The Lancet 386 (9999), 1137-1146, 2015 | 1009 | 2015 |
| Secukinumab inhibition of interleukin-17A in patients with psoriatic arthritis PJ Mease, IB McInnes, B Kirkham, A Kavanaugh, P Rahman, ... New England Journal of Medicine 373 (14), 1329-1339, 2015 | 862 | 2015 |
| Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis … CE Antoni, A Kavanaugh, B Kirkham, Z Tutuncu, GR Burmester, ... Arthritis & Rheumatism 52 (4), 1227-1236, 2005 | 829 | 2005 |
| Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium F Humby, M Bombardieri, A Manzo, S Kelly, MC Blades, B Kirkham, ... PLoS medicine 6 (1), e1, 2009 | 538 | 2009 |
| Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: a two‐year prospective study (the DAMAGE study cohort) BW Kirkham, MN Lassere, JP Edmonds, KM Juhasz, PA Bird, CS Lee, ... Arthritis & Rheumatism 54 (4), 1122-1131, 2006 | 503 | 2006 |
| Prospective evaluation of magnetic resonance imaging and physical examination findings in patients with greater trochanteric pain syndrome PA Bird, SP Oakley, R Shnier, BW Kirkham Arthritis & Rheumatism: Official Journal of the American College of …, 2001 | 463 | 2001 |
| Enthesitis: from pathophysiology to treatment G Schett, RJ Lories, MA D'Agostino, D Elewaut, B Kirkham, ER Soriano, ... Nature reviews rheumatology 13 (12), 731-741, 2017 | 455 | 2017 |
| Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised … P Nash, B Kirkham, M Okada, P Rahman, B Combe, GR Burmester, ... The Lancet 389 (10086), 2317-2327, 2017 | 442 | 2017 |
| Reduction of joint inflammation and bone erosion in rat adjuvant arthritis by treatment with interleukin‐17 receptor IgG1 Fc fusion protein KA Bush, KM Farmer, JS Walker, BW Kirkham Arthritis & Rheumatism 46 (3), 802-805, 2002 | 417 | 2002 |
| Interleukin‐17A: a unique pathway in immune‐mediated diseases: psoriasis, psoriatic arthritis and rheumatoid arthritis BW Kirkham, A Kavanaugh, K Reich Immunology 141 (2), 133-142, 2014 | 353 | 2014 |
| Interleukin‐17+ CD8+ T cells are enriched in the joints of patients with psoriatic arthritis and correlate with disease activity and joint damage progression B Menon, NJ Gullick, GJ Walter, M Rajasekhar, T Garrood, HG Evans, ... Arthritis & rheumatology 66 (5), 1272-1281, 2014 | 314 | 2014 |
| Comparison of two etanercept regimens for treatment of psoriasis and psoriatic arthritis: PRESTA randomised double blind multicentre trial W Sterry, JP Ortonne, B Kirkham, O Brocq, D Robertson, RD Pedersen, ... Bmj 340, 2010 | 301 | 2010 |
| In vivo activated monocytes from the site of inflammation in humans specifically promote Th17 responses HG Evans, NJ Gullick, S Kelly, C Pitzalis, GM Lord, BW Kirkham, ... Proceedings of the National Academy of Sciences 106 (15), 6232-6237, 2009 | 256 | 2009 |
| Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2009 DE Furst, EC Keystone, R Fleischmann, P Mease, FC Breedveld, ... Annals of the Rheumatic Diseases 69 (Suppl 1), i2-i29, 2010 | 247 | 2010 |
| The treatment of disc herniation-induced sciatica with infliximab: one-year follow-up results of FIRST II, a randomized controlled trial T Korhonen, J Karppinen, L Paimela, A Malmivaara, KA Lindgren, ... Spine 31 (24), 2759-2766, 2006 | 218 | 2006 |
| Primary Sjögren's syndrome as a systemic disease: a study of participants enrolled in an international Sjögren's syndrome registry AS Malladi, KE Sack, SC Shiboski, CH Shiboski, AN Baer, R Banushree, ... Arthritis care & research 64 (6), 911-918, 2012 | 213 | 2012 |
| The role of IL-17A in axial spondyloarthritis and psoriatic arthritis: recent advances and controversies DG McGonagle, IB McInnes, BW Kirkham, J Sherlock, R Moots Annals of the rheumatic diseases 78 (9), 1167-1178, 2019 | 211 | 2019 |
| Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2008 DE Furst, EC Keystone, B Kirkham, R Fleischmann, P Mease, ... Annals of the rheumatic diseases 67 (Suppl 3), iii2-iii25, 2008 | 210 | 2008 |
